Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Decreased total neutrophil count; and very common findings: Bone marrow maturation arrest. 7 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 3 | Recurrent bacterial infections, Recurrent respiratory infections, Decreased total neutrophil count |
JAGN1 encodes jagunal vesicle mediated transporter 1 (183 aa). Endoplasmic reticulum transmembrane protein involved in vesicle-mediated transport, which is required for neutrophil function. Highest expression in Cells Cultured fibroblasts (67.6 TPM) and Adrenal Gland (64.6 TPM).
Autosomal recessive severe congenital neutropenia due to JAGN1 deficiency is associated with mutations in the JAGN1 gene on chromosome 3.
JAGN1 is classified as a druggable target with score 0.0.
Genetic testing for JAGN1 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 1 always present feature, 1 very common feature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for autosomal recessive severe congenital neutropenia due to JAGN1 deficiency.
17 publications have been identified in PubMed for autosomal recessive severe congenital neutropenia due to JAGN1 deficiency. Research spans Case Report / Case Series (35%), Epidemiology / Natural History (24%), and Basic Science / Preclinical (18%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 6 | 35% |
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 9:58 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Growth and development
2 |
Short stature, Failure to thrive |
Bones and joints | 1 | Bone marrow maturation arrest |
Ears | 1 | Recurrent otitis media |
Lungs and breathing | 1 | Recurrent respiratory infections |
Disease patterns and progression |
4 |
24% |
Laboratory research | 3 | 18% |
New treatment approaches | 3 | 18% |
Research summaries | 1 | 6% |
Sun Y (2026). [PMID: 41560087](https://pubmed.ncbi.nlm.nih.gov/41560087/). *Medicine*. [Gene Therapy / Novel Therapeutics]
Borg Azzopardi D (2026). [PMID: 41638760](https://pubmed.ncbi.nlm.nih.gov/41638760/). *BMJ case reports*. [Case Report / Case Series]
Pantea CL (2026). [PMID: 41751872](https://pubmed.ncbi.nlm.nih.gov/41751872/). *International journal of molecular sciences*. [Basic Science / Preclinical]
Fekadu-Siebald J (2025). [PMID: 39775668](https://pubmed.ncbi.nlm.nih.gov/39775668/). *Blood Adv*. [Epidemiology / Natural History]
Brouwer MAE (2025). [PMID: 41321749](https://pubmed.ncbi.nlm.nih.gov/41321749/). *EJHaem*. [Case Report / Case Series]
Fonseca M (2025). [PMID: 40698220](https://pubmed.ncbi.nlm.nih.gov/40698220/). *Cureus*. [Basic Science / Preclinical]
Nasri M (2025). [PMID: 39653038](https://pubmed.ncbi.nlm.nih.gov/39653038/). *Molecular therapy : the journal of the American Society of Gene Therapy*. [Gene Therapy / Novel Therapeutics]
Jayakumar NK (2025). [PMID: 40555537](https://pubmed.ncbi.nlm.nih.gov/40555537/). *BMJ case reports*. [Case Report / Case Series]
Pantea CL (2025). [PMID: 40442269](https://pubmed.ncbi.nlm.nih.gov/40442269/). *Sci Rep*. [Basic Science / Preclinical]
Nasri M (2024). [PMID: 38556793](https://pubmed.ncbi.nlm.nih.gov/38556793/). *Molecular therapy : the journal of the American Society of Gene Therapy*. [Epidemiology / Natural History]